Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Slides:



Advertisements
Similar presentations
Managing anticoagulation in atrial fibrillation Dr Katy Rice June 2011.
Advertisements

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.
Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.
Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Update in ESC: Dabigatran among OAC
Exercise Management Atrial Fibrillation Chapter 9.
Atrial fibrillation and subcutaneous monitoring : Will it change our daily practice ? Aymeric MENET Lille January 2016.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for the Management of.
R2. 최태웅 / Pf. 김진배. BACKGROUND  Ischemic stroke : leading causes of death and disability : cause remains unexplained after routine evaluation → Cryptogenic.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Evidence That D-Dimer Levels Predict Subsequent.
Journal of the American College of Cardiology Vol. 61, No. 4, 2013 Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation.
Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective by Michael D. Ezekowitz, Rangadham.
From: Incidence, Predictive Factors, and Prognostic Value of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation J Am Coll.
Cryptogenic Stroke and AF
Discontinuation of medication after nonfatal event: MI
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
An approach to using risk scores for stroke and bleeding in clinical practice. An approach to using risk scores for stroke and bleeding in clinical practice.
Algorithm for the treatment of atrial fibrillation (AF) and atrial flutter. (BB, β-blocker; CCB, calcium channel blocker [i.e., verapamil or diltiazem];
Nat. Rev. Cardiol. doi: /nrcardio
No evidence that AF type significantly impacts stroke risk
Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.
C. ACC/AHA/ESC guidelines Role of anticoagulant therapy in AF
by Anuj Shah, Anand Shewale, Corey J. Hayes, and Bradley C. Martin
Monitoring Continuum ISSUE-3 Atrial Fibrillation Classification.
Appropriate Stroke Prevention Strategies in Atrial Fibrillation
Nat. Rev. Cardiol. doi: /nrcardio
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
Applying Real-World Evidence in Atrial Fibrillation Into Clinical Care:
Left atrial appendage closure: A new technique for clinical practice
A. Epidemiology update:
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Identifying High-Risk AF Patients
AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top.
Figure 2 Absolute difference in seasonal peak
Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?
Figure 3 U‑shape relationship between exercise dose and risk of atrial fibrillation (AF) Figure 3 | U-shape relationship between exercise dose and risk.
Optimizing Atrial Fibrillation Management
The procedural journey for our cohort of patients with persistent atrial fibrillation. The procedural journey for our cohort of patients with persistent.
Björn Redfors et al. JACEP 2017;j.jacep
Anna Björkenheim et al. JACEP 2017;j.jacep
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
Pamela E. Scott et al. JACC 2018;71:
Final CM for the early HTA of current and novel heart valve interventions. Final CM for the early HTA of current and novel heart valve interventions. Cerebrovascular.
Receiver operating characteristics curve of N-terminal pro-atrial natriuretic peptide plasma levels (dark line) and brain natriuretic peptide (dashed line)
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
(p for noninferiority = 0.01)
Real-World Data in Cardiology: Focus on Atrial Fibrillation
Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.
Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
OPN is elevated in patients with symptomatic AS
Vivek Y. Reddy et al. JACEP 2019;j.jacep
Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
Vivek Y. Reddy et al. JACEP 2019;j.jacep
Figure 8. Stroke prevention strategy in patients with AF
Gianluigi Savarese et al. JCHF 2016;4:
Forest plot illustrating the risk ratio of major bleeding
Forest plot of all-cause mortality (ACM) in CRT patient with AF comparing atrioventricular junction ablation (AVJA) versus no AVJA. AF, atrial fibrillation;
Left atrial appendage flow during atrial fibrillation, as determined by pulsed Doppler during transoesophageal echocardiography. Left atrial appendage.
Forest plot illustrating the risk ratio of myocardial infarction
Forest plot illustrating risk ratio of stent thrombosis
The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.
Presentation transcript:

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal AF not on anticoagulation, who underwent a 14-day ambulatory electrocardiographic monitoring 5 events/690 p-y 7 events/639 p-y 17 events/586 p-y Tertiles of AF burden are expressed in percentage of time with AF AF: atrial fibrillation; KP-RHYTHM: Kaiser Permanente Real-World Heart Monitoring Strategy Evaluation, Treatment Patterns, and Health Metrics in Atrial Fibrillation; TE: thromboembolic Go et al. JAMA Cardiol 2018

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.